ArticleJournal of medical imaging (Bellingham, Wash.)2023
Standardized CycleGAN training for unsupervised stain adaptation in invasive carcinoma classification for breast histopathology.
Article in Journal of medical imaging (Bellingham, Wash.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- VISGAB: Virtual staining-driven GAN benchmarking for optimizing skin tissue histology.Scientific reports · 2025Article
- Evaluating AI-Based Mitosis Detection for Breast Carcinoma in Digital Pathology: A Clinical Study on Routine Practice Integration.Diagnostics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Generalization is one of the main challenges of computational pathology. Slide preparation heterogeneity and the diversity of scanners lead to poor model performance when used on data from medical centers not seen during training. In order to achieve stain invariance in breast invasive carcinoma patch classification, we implement a stain translation strategy using cycleGANs for unsupervised image-to-image translation. Those models often suffer from a lack of proper metrics to monitor and stop the training at a particular point. We also introduce a method to solve this issue. Approach: We compare three CycleGAN-based approaches to a baseline classification model obtained without any stain invariance strategy. Two of the proposed approaches use CycleGAN's translations at inference or training to build stain-specific classification models. The last method uses them for stain data augmentation during training. This constrains the classification model to learn stain-invariant features. Regarding CycleGANs' training monitoring, we leverage Fréchet inception distance between generated and real samples and use it as a stopping criterion. We compare CycleGANs' models stopped using this criterion and models stopped at a fixed number of epochs. Results: Baseline metrics are set by training and testing the baseline classification model on a reference stain. We assessed performances using three medical centers with H&E and H&E&S staining. Every approach tested in this study improves baseline metrics without needing labels on target stains. The stain augmentation-based approach produced the best results on every stain. Each method's pros and cons are studied and discussed. Moreover, FID stopping criterion proves superiority to methods using a predefined number of training epoch and has the benefit of not requiring any visual inspection of CycleGAN results. Conclusion: We introduce a method to attain stain invariance for breast invasive carcinoma classification by leveraging CycleGAN's abilities to produce realistic translations between various stains. Moreover, we propose a systematical method for scheduling CycleGANs' trainings by using FID as a stopping criterion and prove its superiority to other methods. Finally, we give an insight on the minimal amount of data required for CycleGAN training in a digital histopathology setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.